N. Mestdagh et al., EXPRESSION OF A TUMOR-SUPPRESSOR GENE AND OF VARIOUS PROTOONCOGENES IN HUMAN AND MURINE ADRIAMYCIN-RESISTANT AND SENSITIVE CELL-LINES, International journal of oncology, 6(6), 1995, pp. 1255-1260
Besides established mechanisms involved in cellular drug resistance in
cluding P-glycoprotein overexpression, topoisomerase alterations and x
enobiotic detoxification, the hypothesis that proto-oncogene activatio
n might also play a role in cell resistance has been postulated. This
hypothesis has been tested by comparing the expression of various prot
o-oncogenes involved in signal transduction pathways (c-H-ras, c-g-ras
, c-mil, c-myc, c-myb, c-fos), as well as the mdr gene and a tumor sup
pressor gene (p53) in different adriamycin-resistant (acquired or de n
ovo) or sensitive cell lines, The implication of these variations in t
he process of chemoresistance is discussed.